A McDonald’s, $MCD, test of its plant-based burger in San Francisco and Dallas “was not successful in either market"

A McDonald’s, $MCD, test of its plant-based burger in San Francisco and Dallas “was not successful in either market,” per CNBC.

A test of its McPlant burger in San Francisco and Dallas "was not successful in either market," said Joe Erlinger, the chain’s US chief, at the Wall Street Journal’s Global Food Forum in Chicago. That test concluded in 2022, according to the company following Erlinger's remarks.

US consumers aren’t interested in "McPlant or other plant-based proteins from McDonald’s," he added. The company has noted that plant-based food has performed better in European markets.

Erlinger also mentioned that "if people really want salads from McDonald’s, we will gladly relaunch salads. But our experience has shown that’s not what the consumer is looking for."

Shares of Beyond Meat Inc., which has partnered with McDonald’s to produce the McPlant burger, recovered from an earlier decline and were relatively unchanged as of 1:38 p.m. in New York trading on Wednesday. McDonald’s shares also remained relatively stable.

Instead of plant-based options, McDonald’s is focusing on its chicken offerings as consumers show a preference for that protein. The company now sells more chicken than beef, Erlinger added.

"Some of it’s driven by affordability," he said. "Chicken is less expensive to produce, and for consumers seeking more affordable food, chicken is a great option right now."

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.